N/A
Manufactured by Chartwell RX, LLC
9,068 FDA adverse event reports analyzed
Last updated: 2026-04-15
CYPROHEPTADINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chartwell RX, LLC. The most commonly reported adverse reactions for CYPROHEPTADINE HYDROCHLORIDE include OFF LABEL USE, DRUG INEFFECTIVE, DIARRHOEA, VOMITING, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CYPROHEPTADINE HYDROCHLORIDE.
Out of 4,178 classified reports for CYPROHEPTADINE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 9,068 FDA FAERS reports that mention CYPROHEPTADINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include OFF LABEL USE, DRUG INEFFECTIVE, DIARRHOEA, VOMITING, FATIGUE, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Chartwell RX, LLC in connection with CYPROHEPTADINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.